Furthermore, the CD8+ T cell depletion assay, using anti-CD8 mAb to deplete CD8+ T cells in vivo, was performed to determine whether functional CD8+ T cells were essential for the anti-tumor activity induced by the Ad-CAIX/Ad-PD-L1 vaccine. The gene discussed is CA9; the disease is neoplasm.